Syahrul Imran Abu Bakar (Syahrul Imran)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Venues

Molecular diversity

Chemical biology & drug design

Journal of biomolecular structure & dynamics

Pharmaceuticals (Basel, Switzerland)

UiTM

Universiti Teknologi MARA Fakulti Farmasi (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UiTM Aug 01 2016 - May 14 2017

Malaysia

Postdoctoral scholar :: Atta-ur-Rahman Institute for Natural Product Discovery

Kotra Pharma M Sdn Bhd Sep 11 2011 - Feb 28 2013

Malaysia

Analytical Method Development and Validation Chemist :: Quality Control

Education History

Universiti Teknologi MARA Fakulti Farmasi Mar 01 2013 - Jul 18 2016

Malaysia

PHD :: Atta-ur-Rahman Institute for Natural Product Discovery

Universiti Teknologi MARA Jun 01 2009 - Jun 01 2011

Malaysia

BSC :: Faculty of Applied Sciences

Publications

Nurul Alam Inayatsyah, Mohamad Jemain Mohamad Ridhwan, Alim Alsukor Aznirulhisham, Nurulfazlina Edayah Rasol, Noraini Kasim, Syahrul Imran Abu Bakar
Synthesis of Novel Soritin Sulfonamide Derivatives as Potential α-Glucosidase Inhibitor and Their Molecular Docking Studies. Chemical biology & drug design 104 (3) (2024)
Muhammad Taha, Fazal Rahim, Shawkat Hayat, Sridevi Chigurupati, Khalid Mohammed Khand, Syahrul Imran Abu Bakar, Syed Adnan Ali Shah, Nizam Uddin, Shatha Ghazi Felemban, Vijayan Venugopal
New pyrrolopyridine-based thiazolotriazoles as diabetics inhibitors: enzymatic kinetics and in silico study. Future medicinal chemistry (2023)
Naheed Akhter, Sidra Batool, Samreen Gul Khan, Nasir Rasool, Fozia Anjum, Azhar Rasul, Şevki Adem, Sadaf Mahmood, Aziz Ur Rehman, Mehr Un Nisa, Zainib Razzaq, Jørn Bolstad Christensen, Mohammad A S Abourehab, Syed Adnan Ali Shah, Syahrul Imran Abu Bakar
Bio-Oriented Synthesis and Molecular Docking Studies of 1,2,4-Triazole Based Derivatives as Potential Anti-Cancer Agents against HepG2 Cell Line. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Nor Atiqah Jusril, Syahrul Imran Abu Bakar, Khalilah Abdul Khalil, Wan Mazlina Md Saad, Kwok Wen Ng, Mohd Ilham Adenan
Development and Optimization of Nanoemulsion from Ethanolic Extract of Centella asiatica (NanoSECA) Using D-Optimal Mixture Design to Improve Blood-Brain Barrier Permeability. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Muhammad Taha, Sukinah Ismail, Syahrul Imran Abu Bakar, Noor Barak Almandil, Munther Alomari, Fazal Rahim, Nizam Uddin, Shawkat Hayat, Khalid Zaman, Mohamad Ibrahim, Bandar Alghanem, Imadul Islam, Rai Khalid Farooq, Mohamed Boudjelal, Khalid Mohammed Khan
Synthesis of new urease enzyme inhibitors as antiulcer drug and computational study. Journal of biomolecular structure & dynamics (2021)
Obaidurahman Abid, Syahrul Imran Abu Bakar, Muhammad Taha, Nor Hadiani Ismail, Waqas Jamil, Syed Muhammad Kashif, Khalid Mohammed Khan, Juliana Yusoff
Synthesis, β-glucuronidase inhibition and molecular docking studies of cyano-substituted bisindole hydrazone hybrids. Molecular diversity 25 (2) (2020)
Nor Atiqah Jusril, Ain Nur Najihah Muhamad Juhari, Syahrul Imran Abu Bakar, Wan Mazlina Md Saad, Mohd Ilham Adenan
Combining In Silico and In Vitro Studies to Evaluate the Acetylcholinesterase Inhibitory Profile of Different Accessions and the Biomarker Triterpenes of Centella asiatica. Molecules (Basel, Switzerland) 25 (15) (2020)

Syahrul Imran Abu Bakar.css-eqlu8i{font-size:small;padding-left:4px;} (Syahrul Imran)

Publication Activity (10 Years)

Top Topics

Top Venues

Syahrul Imran Abu Bakar (Syahrul Imran)